Clinical Trial Update: Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Penpulimab in combination with Anlotinib and chemotherapy for esophageal cancer. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Penpulimab

Snippet

Sponsor: Xijing Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING